Literature DB >> 11422382

Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I.

C Bergt1, G Marsche, U Panzenboeck, J W Heinecke, E Malle, W Sattler.   

Abstract

The structural integrity of apolipoprotein A-I (apo A-I) is critical to the physiological function of high-density lipoprotein (HDL). Oxidized lipoproteins are thought to be of central importance in atherogenesis, and oxidation products characteristic of myeloperoxidase, a heme protein secreted by activated phagocytes, have been detected in human atherosclerotic tissue. At plasma concentrations of halide ion, hypochlorous acid is a major product of the myeloperoxidase-hydrogen peroxide-chloride system. We therefore investigated the effects of activated human neutrophils, a potent source of myeloperoxidase and hydrogen peroxide, on the protein and lipid components of HDL. Both free and HDL-associated apo A-I exposed to activated human neutrophils underwent extensive degradation as monitored by RP-HPLC and Western blotting with a polyclonal antibody to apo A-I. Replacement of the neutrophils with reagent HOCl resulted in comparable damage (at molar oxidant : HDL subclass 3 ratio = 100) as observed in the presence of activated phagocytes. Apo A-I degradation by activated neutrophils was partially inhibited by the HOCl scavenger methionine, by the heme inhibitor azide, by chloride-free conditions, by the peroxide scavenger catalase, and by a combination of superoxide dismutase (SOD)/catalase, implicating HOCl in the cell-mediated reaction. The addition of a protease inhibitor (3,4-dichloroisocoumarin) further reduced the extent of apo A-I damage. In contrast to the protein moiety, there was little evidence for oxidation of unsaturated fatty acids or cholesterol in HDL3 exposed to activated neutrophils, suggesting that HOCl was selectively damaging apo A-I. Our observations indicate that HOCl generated by myeloperoxidase represents one pathway for protein degradation in HDL3 exposed to activated phagocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422382     DOI: 10.1046/j.1432-1327.2001.02253.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

Review 1.  The use of myeloperoxidase as a risk marker for atherosclerosis.

Authors:  Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

2.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Authors:  Gunther Marsche; Sasa Frank; John G Raynes; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

3.  Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport.

Authors:  Priya Malik; Stela Z Berisha; Jennifer Santore; Colin Agatisa-Boyle; Gregory Brubaker; Jonathan D Smith
Journal:  J Lipid Res       Date:  2011-02-19       Impact factor: 5.922

4.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

5.  Characterization of non-covalent oligomers of proteins treated with hypochlorous acid.

Authors:  Anna L P Chapman; Christine C Winterbourn; Stephen O Brennan; T William Jordan; Anthony J Kettle
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

6.  A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages.

Authors:  Joanna Shepherd; Scott A Hilderbrand; Peter Waterman; Jay W Heinecke; Ralph Weissleder; Peter Libby
Journal:  Chem Biol       Date:  2007-11

7.  Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.

Authors:  Alexander B Sigalov
Journal:  Contrast Media Mol Imaging       Date:  2014-04-14       Impact factor: 3.161

8.  Synthesis of a highly HOCl-selective fluorescent probe and its use for imaging HOCl in cells and organisms.

Authors:  Xiaoqiang Chen; Kyung-Ah Lee; Xintong Ren; Jae-Chan Ryu; Gyungmi Kim; Ji-Hwan Ryu; Won-Jae Lee; Juyoung Yoon
Journal:  Nat Protoc       Date:  2016-06-09       Impact factor: 13.491

9.  Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.

Authors:  Carolyne K Smith; Anuradha Vivekanandan-Giri; Chongren Tang; Jason S Knight; Anna Mathew; Robin L Padilla; Brenda W Gillespie; Carmelo Carmona-Rivera; Xiaodan Liu; Venkataraman Subramanian; Sarfaraz Hasni; Paul R Thompson; Jay W Heinecke; Rajiv Saran; Subramaniam Pennathur; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

10.  A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock.

Authors:  Alexander B Sigalov
Journal:  Int Immunopharmacol       Date:  2014-05-14       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.